DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.
About DECHEMA
DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V. (Society for Chemical Engineering and Biotechnology) brings together experts from a wide range of disciplines, institutions and generations to stimulate scientific exchange in chemical engineering, process engineering and biotechnology. We identify and evaluate emerging technological trends and facilitate the transfer of research results into industrial applications. DECHEMA is the hub of an interdisciplinary network of topic-oriented committees, organizing events and professional development courses for all who are interested in a specialized subject area. DECHEMA has over 5,800 members - individuals, institutions and companies. The Biotechnology Section and ProcessNet, the joint platform for chemical engineering, are the forums where scientists, engineers, students, companies and institutions meet for knowledge exchange and discussion. In addition, we administer funding programmes as well as national and European research clusters. As a member of AiF we organize industrial cooperative research projects. Together with DECHEMA Ausstellungs-GmbH we are the organizers of ACHEMA, the world forum for the process industry. We cooperate closely with the DECHEMA-Forschungsinstitut, which is dedicated to research for sustainable technologies in biotechnology, materials science and chemical engineering.
- Employees : 51-200
- Industry : Chemistry
Product portfolio of DECHEMA
News about DECHEMA
Here you will find DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.
Last viewed contents
Dako and Quintiles form alliance to speed development of personalized medicine
Metobolomics uncovers key indicators of nonalcoholic fatty liver disease - Impaired oxidation in liver associated with progression to NASH
“Viral relicts” in the Genome Could Fuel Neurodegeneration - Researchers see ancient genes as potential targets for dementia treatment
U.S. Development Partner Quest Diagnostics Completes Clinical Development of Septin9 Colorectal Cancer Blood Test
Artificial intelligence recognizes heart disease by the sound of the voice - AI from a Berlin start-up is used for this purpose
Analytica USA: New meeting place for the laboratory industry - Premiere in September 2025 in Columbus, Ohio
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease - Combination of Proprietary Drug Targets and Unique Technologies to Create Range of New Therapeutic Antibodies
Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management
Alzheimer’s: modulation of cell membrane influences formation of amyloid-β - Adding long-chain fatty acids can thicken cell membranes and alter the activity of a key enzyme
Health tech startup Carelane sets new standards for clinical research with AI-driven, end-to-end platform - Seed funding of EUR 2.6 million led by Vorwerk Ventures
